Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Hiren Patel
JCP
Perspective
The US Food and Drug Administration's Perspective on the New Antidepressant Vortioxetine
PCC
Commentary
Opioid Use Disorder Treatment and Interaction With COVID-19 Medication
In this commentary, the authors discuss the potential interactions of opioid use disorder treatments with novel COVID-19 medications.
PCC
Letter to the Editor
Interactions With IL-6 Inhibitors and Agents for Opioid Use: Drs Mansuri and Colleagues Reply
In this letter to the editor, the authors reply to Kow and Hasan.
PCC
Original Research
Psychiatric Comorbidities of Neurofibromatosis
Neurofibromatosis is a group of inherited neurocutaneous disorders that includes neurofibromatosis types 1 and 2 and schwannomatosis. This study assessed the prevalence of psychiatric comorbidities in patients with neurofibromatosis.
PCC
Letter to the Editor
Intravenous Ketamine vs Intranasal Esketamine for TRD
Dr Mansuri and colleagues compare the pros and cons of IV ketamine and intranasal esketamine for treatment-resistant depression.